Karuna Therapeutics
Biotech · Acquired
Muscarinic receptor agonist small-molecule therapeutics for schizophrenia and Alzheimer's disease
karunatx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 8 granted · 32 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1557 | Luxvitae Therapeutics Inc. | — | $8.5M |
| 1558 | Orbis Medicines | — | — |
| 1559 | TRANSPORIN, INC. | — | — |
| 1560 | Karuna Therapeutics | — | — |
| 1561 | Sudo Biosciences | — | $63M |
| 1562 | TROPHOGEN INC | — | — |
| 1563 | Anjon Biologics Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compositions And Methods For Treating Disorders Ameliorated By Muscarinic Receptor Activationapplication
- Substituted Tetrahydropyrrolo-pyridinone Compounds And Their Use In Treating Medical Conditionsapplication
- Compositions And Methods For Treating Disorders Ameliorated By Muscarinic Receptor Activationgranted
- Substituted Tetrahydropyrrolo-pyridinone Compounds And Their Use In Treating Medical Conditionsgranted
- Methods For Treating Disorders Ameliorated By Muscarinic Receptor Activationapplication
- Methods For Treating Disorders Ameliorated By Muscarinic Receptor Activationapplication
- Compositions And Methods For Treating Disorders Ameliorated By Muscarinic Receptor Activationgranted
- Xanomeline Derivatives And Methods For Treating Neurological Disordersgranted
- Methods For Treating Central Nervous System Disorders With Muscarinic Receptor Activation And Antipsychoticsapplication
- Compositions And Methods For Treating Disorders Ameliorated By Muscarinic Receptor Activationgranted
- Compositions And Methods For Treating Disorders Ameliorated By Muscarinic Receptor Activationgranted
- Compounds And Methods Of Deuterated Xanomeline For Treating Neurological Disordersapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.